A Phase I/II Study of CAR.70-Engineered IL15-Transduced Cord Blood-Derived NK Cells With TGF-beta Receptor 2 (TGFBR2) Knock Out in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapsed/Refractory Myeloid Malignancies
Phase 1
Not yet recruiting
- Conditions
- Myeloid Malignancies
- Interventions
- First Posted Date
- 2025-04-16
- Last Posted Date
- 2025-04-16
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 42
- Registration Number
- NCT06930651
- Locations
- ๐บ๐ธ
The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States
Chronic Loose Stools Following Right-sided Hemicolectomy for Colon Cancer and the Association With Bile Acid Malabsorption and Small Intestinal Bacterial Overgrowth Using a Novel Sampling Device
Not yet recruiting
- Conditions
- Colon Cancer
- First Posted Date
- 2025-04-15
- Last Posted Date
- 2025-04-15
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 20
- Registration Number
- NCT06927011
- Locations
- ๐บ๐ธ
MD Anderson Cancer Center, Houston, Texas, United States
Dyadic Yoga Program for Patients Undergoing Thoracic Radiotherapy and Their Family Caregivers: The Testing of a Mobile Application Delivery
Not Applicable
Not yet recruiting
- Conditions
- Non-Small Cell Lung Cancer
- First Posted Date
- 2025-04-09
- Last Posted Date
- 2025-04-09
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 60
- Registration Number
- NCT06919874
- Locations
- ๐บ๐ธ
The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States
Assessing User Satisfaction and Adherence to an Abbreviated Dietary Tracking App (MySnackTracker) Versus Full-intake Dietary Monitoring
Not Applicable
Active, not recruiting
- Conditions
- Dietary Monitoring
- First Posted Date
- 2025-04-09
- Last Posted Date
- 2025-05-08
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 90
- Registration Number
- NCT06919471
- Locations
- ๐บ๐ธ
MD Anderson Cancer Center, Houston, Texas, United States
Reversing External-beam Radiotherapy-associated Fibrosis Syndrome: an Interventional Bayesian Adaptive Randomized-controlled Orphan Drug Platform Trial for Orodental Sequelae (Reverse-fibrose)
Phase 2
Not yet recruiting
- Conditions
- Fibrosis SyndromeLymphedemaHead &Amp; Neck CancerFibrosis
- Interventions
- Drug: PirfenidoneoneOther: Standard of Care (SOC)
- First Posted Date
- 2025-04-06
- Last Posted Date
- 2025-04-06
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 250
- Registration Number
- NCT06912763
- Locations
- ๐บ๐ธ
MD Anderson Cancer Center, Houston, Texas, United States
Hyperpolarized Xenon-129 Magnetic Resonance Imaging in Lung Cancer Patients Receiving Radiation Therapy for Investigating Radiation-response and Toxicity
Early Phase 1
Not yet recruiting
- Conditions
- Lung Cancer
- Interventions
- Drug: HP 129Xe MRI
- First Posted Date
- 2025-04-03
- Last Posted Date
- 2025-04-09
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 70
- Registration Number
- NCT06909201
- Locations
- ๐บ๐ธ
The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States
Active Living After Cancer: Implementation Within Be Well Acres Homes
Not Applicable
Recruiting
- Conditions
- CancerFatigue
- First Posted Date
- 2025-04-02
- Last Posted Date
- 2025-04-02
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 164
- Registration Number
- NCT06907706
- Locations
- ๐บ๐ธ
The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States
A Phase I Study of the NovoTTF-200M and Novo TTF-200A Systems for the Treatment of Refractory Spinal Metastasis
Phase 1
Not yet recruiting
- Conditions
- Spinal Metastasis
- First Posted Date
- 2025-04-02
- Last Posted Date
- 2025-04-02
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 30
- Registration Number
- NCT06906900
- Locations
- ๐บ๐ธ
The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States
EMERALD: Endocrine Therapy oMission With Radiation in ER+ Breast Cancer: Assessing Quality of Life and Disease Control: a Prospective Phase II Trial
Phase 2
Not yet recruiting
- Conditions
- Breast Cancer
- First Posted Date
- 2025-03-27
- Last Posted Date
- 2025-03-27
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 300
- Registration Number
- NCT06897488
- Locations
- ๐บ๐ธ
The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States
Supporting Informed Decision Making About Multi-cancer Early Detection Testing
Recruiting
- Conditions
- Multi-cancer Early Detection
- First Posted Date
- 2025-03-25
- Last Posted Date
- 2025-03-28
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 150
- Registration Number
- NCT06870916
- Locations
- ๐บ๐ธ
MD Anderson Cancer Center, Houston, Texas, United States
ยฉ Copyright 2025. All Rights Reserved by MedPath